This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Compare capital gains tax exposure between ETFs and index funds in retirement, and choose the option with better tax efficiency.
28,430 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
The Trade Desk surged after a large insider purchase by its CEO, lifting the stock among S&P 500 movers as Palantir a...
As Citi gears up for its 2026 earnings call, investors need a clear view of the revenue mix, credit quality, and capi...
Target’s stock has surged 33% from October lows, prompting renewed questions about a possible buyout. This report ana...
Fluor shares sit at a crossroads as the mix between reimbursable and fixed-price contracts shapes earnings. This guid...
As AI accelerates, Microsoft reports robust AI-driven revenue while stock faces capex-related volatility. This piece ...
Investors are asking if sofi stock finally bottomed? This guide breaks down the signals, what the data actually shows...
Interloom just raised $16.5 million to convert tacit knowledge into AI-driven workflow tools. The Munich startup says...
Energy Transfer is shifting from a pure yield play to a growth story as key midstream projects advance. This long-for...
After a dramatic surge, investors want to know if Iren stock still after the rally makes sense. This article breaks d...
As Hormel gears up for Q1 2026 disclosures, investors want a clear read on margins, demand, and cash flow. This guide...
Q1 2026 earnings transcripts reveal more than quarterly numbers. Explore how guidance, margin trends, and management ...